CTOs on the Move

Operatrix Consulting

www.operatrix.com

 
Operatrix Consulting Inc. is a Waterdown, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.operatrix.com
  • PO Box 277 8 Nancy Ct
    Waterdown, ON CAN L0R 2H0
  • Phone: 905.690.1200

Executives

Name Title Contact Details

Similar Companies

Teva Neuroscience

Teva Neuroscience is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Kansas City, MO. To find more information about Teva Neuroscience, please visit www.tevaneuro.com

Golo

GOLO is a pioneering wellness solutions company that empowers individuals by helping them take control of their personal health. The company provides safe and effective solutions for weight loss and wellness while helping customers transition to a healthier and sustainable lifestyle. To date, GOLO has reached over two million people worldwide who now have a chance at a healthier life.

Mirror

Mirror uses your personal fitness profile and your biometric data to optimize every workout for maximum results. Receive real-time instruction from best-in-class instructors, work out with friends and track your progress.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Ascension

Ascension is one of the largest private healthcare systems in the United States, ranking second in the United States by number of hospitals as of 2019.